Category Ranking
98%
Total Visits
921
Avg Visit Duration
2 minutes
Citations
20
Article Abstract
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.ajog.2023.07.011 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Corrigendum to "Comparison of effectiveness of the levonorgestrel intrauterine system and dienogest in the management of adenomyosis: A systematic review and meta-analysis" [Eur. J. Obstetr. Gynecol. Reprod. Biol. 300 (2024) 230-239].
Eur J Obstet Gynecol Reprod Biol
July 2025
Department of Physiology, Ladoke Akintola University of Technology, Ogbomoso, Oyo State, Nigeria.
Corrigendum to 'Biological characteristics related to treatment effects of the levonorgestrel-releasing intrauterine system on adenomyosis-associated dysmenorrhoea' Reproductive BioMedicine Online, 2024, 49;6:104393.
Reprod Biomed Online
March 2025
Department of Obstetrics and Gynecology, Peking Union Medical College Hospital, Chinese Academy of Medical Science and Peking Union Medical College, Beijing, China. Electronic address:
Corrigendum to 'Levonorgestrel 52 mg intrauterine system efficacy and safety through 8 years of use' [American Journal of Obstetrics and Gynecology 2022;227:871.e1-871.e7].
Am J Obstet Gynecol
September 2023
Medicines 360, San Francisco, CA.
Corrigendum to "Double-blind, randomized, placebo-controlled study on the effect of misoprostol on ease of consecutive insertion of the levonorgestrel-releasing intrauterine system".
Contraception
March 2023
Karolinska Institutet and Karolinska University Hospital, Stockholm, Sweden. Electronic address:
Corrigendum to "Complete pathological response following levonorgestrel intrauterine device in clinically stage 1 endometrial adenocarcinoma: Results of a randomized clinical trial" [Gynecologic Oncology 161 (2021) 143-151].
Gynecol Oncol
August 2021
Queensland Centre for Gynaecological Cancer Research, The University of Queensland, QLD, Australia; Royal Brisbane and Women's Hospital, Herston, QLD, Australia. Electronic address: